Target intelligence / Profile preview

ANKRD62P1-PARP4P3 readthrough, transcribed pseudogene (ANKRD62P1-PARP4P3)

Target
ANKRD62P1-PARP4P3
Molecular classification
Pseudogene, Non-coding RNA (likely readthrough transcript), Other
01

Overview

ANKRD62P1-PARP4P3 readthrough, transcribed pseudogene is a natural readthrough locus that joins two annotated pseudogenes: ankyrin repeat domain 62 pseudogene 1 (ANKRD62P1) and poly(ADP-ribose) polymerase family member 4 pseudogene 3 (PARP4P3). This region is classified as a pseudogene and is transcribed, but the resulting RNA is unlikely to encode a functional protein product. Neither parent pseudogene, nor the readthrough transcript, has a curated, protein-coding function, and there is no evidence it acts as a canonical therapeutic target such as a receptor, enzyme, transporter, or regulatory protein[1][6]. Pseudogenes generally may have regulatory or evolutionary roles at the RNA level, but for this specific readthrough, no defined biological or pathological function has been described[1][2][5].

Other names
VWFP1-ANKRD62P1-PARP4P3ADPRTL4PARP4P3[6]
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on ANKRD62P1-PARP4P3 readthrough, transcribed pseudogene (ANKRD62P1-PARP4P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD62P1-PARP4P3 readthrough, transcribed pseudogene (ANKRD62P1-PARP4P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call